Basics Standard BioTools Inc. IPO Date: March 1, 2011 Sector: Healthcare Industry: Diagnostics and Research Market Cap: $488.95M Activated in VL: True Average Daily Range Avg Daily Range: $0.07 | 3.54% Avg Daily Range (30 D): $0.04 | 3.06% Avg Daily Range (90 D): $0.04 | 2.89% Institutional Daily Volume Avg Daily Volume: .28M Avg Daily Volume (30 D): 1.2M Avg Daily Volume (90 D): 1.44M Trade Size Avg Trade Size (Sh.): 189 Avg Trade Size (Sh.) (30 D): 206 Avg Trade Size (Sh.) (90 D): 232 Institutional Trades Total Inst.Trades: 119 Avg Inst. Trade: $1.82M Avg Inst. Trade (30 D): $.95M Avg Inst. Trade (90 D): $.96M Avg Inst. Trade Volume: .94M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.97M Avg Closing Trade (30 D): $1.35M Avg Closing Trade (90 D): $1.1M Avg Closing Volume: 1.59M     News Jul 21, 2025 @ 11:00 AM Standard BioTools Schedules Second Quarter Earning... Source: Marissa Bychir Apr 22, 2025 @ 11:00 AM Standard BioTools Schedules First Quarter Earnings... Source: N/A Jan 13, 2025 @ 12:00 PM Standard BioTools Announces Preliminary Fourth Qua... Source: N/A Dec 19, 2024 @ 1:00 PM Standard BioTools to Present at the 43rd Annual J.... Source: N/A Nov 7, 2024 @ 1:00 PM Standard BioTools Appoints Alex Kim as Chief Finan... Source: Standard Biotools Inc. Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.09 $-.07 $-.08 Diluted EPS $-.09 $-.07 $-.08 Revenue $ 21.76M $ 40.8M $ 46.72M Gross Profit $ 10.63M $ 19.74M $ 21.91M Net Income / Loss $ -33.46M $ -26.03M $ -34.07M Operating Income / Loss $ -25.7M $ -32.97M $ -32.82M Cost of Revenue $ 11.13M $ 21.05M $ 24.81M Net Cash Flow $ 7.73M $ -15.35M $ -43.12M PE Ratio